CML Treatment: Scenarios that Necessitate Switching Therapy

Opinion
Video

Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following questions:

  • In which scenarios do you consider switching CML therapies, and how do you approach that conversation with patients? How does the patient experience change when switching therapies?
Recent Videos
A panel of 3 experts on CML
A panel of 3 experts on CML
A panel of 3 experts on CML
A panel of 3 experts on CML
A panel of 3 experts on CML
A panel of 3 experts on CML
A panel of 3 experts on CML
A panel of 3 experts on CML
© 2024 MJH Life Sciences

All rights reserved.